ALEXANDRIA, VA, Oct. 13, 2016 -- ALEXANDRIA, VA - SynGlyphX®, the leading provider of 3D interactive data visualization and discovery technology, announced today that Duke University Medical Center has renewed and increased the number of its licenses for the SynGlyphX® GlyphIT® suite of software. The GlyphIT® suite simplifies interactions with complex data for nontechnical users. An interactive 3D visual representation of data, GlyphIT® allows users to see more of their data at one time on a single screen, so they can more quickly discover insights in their data.
Schultz describes the analytical efficiencies and effectiveness of GlyphIT® in a paper: On Your Mark, Get Set Go, Using data visualization software to get there quicker and without missing landmarks - a case study in healthcare research. Schultz has presented the paper at peer conferences and events. Duke Medical Center and SynGlyphX have submitted a new paper for publication.
Duke University Medical Center renewed its’ GlyphIT® licenses to augment traditional research methodologies. In 2015, using the GlyphIT® suite of software, the Duke University Medical Center team discovered that tonsillectomy patients of Hispanic ethnicity had a 312% higher likelihood of a post-operative bleed rate. The team was reviewing tonsillectomy data within GlyphIT® to discover insights that were previously unseen in the standard methods of analysis.
“SynGlyphX adds significant efficiencies to our research,” says Kristine A. Schulz, DrPHa of Duke Medical Center. “When we analyze our data within its’ GlyphIT®, we can quite literally see patterns, trends, and anomalies in the data that we do not find in traditional analysis.”
“Working with Duke Medical Center has been incredibly rewarding,” said Mark Sloan Co-founder and CEO of SynGlyphX. “The discoveries that they have made using its’ GlyphIT® have far reaching impacts for patients, medical practitioners and researchers. Their renewal is further proof of the power of SynGlyphX® to help people to discover insights that change their world.”
SynGlyphX® understands how the mind assimilates and processes complex data. Its unique approach to interactive visualization technology is enhanced by Perceptual Engineering -- the optimal design of a visual environment to enable the user to more efficiently interact with and synthesize complex data sets. This approach is supported by decades of academic and government-funded research on how the mind best understands and processes complex data.
Government CIO Outlook has ranked SynGlyphX™ among the Top 10 Big Data Solution Providers 2016.
About SynGlyphX®
Headquartered in VA, U.S., SynGlyphX® is transforming the way the world interacts with data for discovery and insight. With superior technology, perceptual engineering and knowledgeable staff, it offers its customers the ability to assimilate massive amounts of data in a single computer screen, allowing user to identify patterns, trends, and anomalies and ultimately transform data to knowledge faster. For more info: http://www.SynGlyphX.com/
Contact: Pam Kadlubek (571) 733-9471 [email protected]


Nintendo Shares Slide After Earnings Miss Raises Switch 2 Margin Concerns
Anthropic Eyes $350 Billion Valuation as AI Funding and Share Sale Accelerate
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge
Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate
Tencent Shares Slide After WeChat Restricts YuanBao AI Promotional Links
AMD Shares Slide Despite Earnings Beat as Cautious Revenue Outlook Weighs on Stock
Nvidia Nears $20 Billion OpenAI Investment as AI Funding Race Intensifies
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates
Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains
CK Hutchison Launches Arbitration After Panama Court Revokes Canal Port Licences
FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns
Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies
SpaceX Pushes for Early Stock Index Inclusion Ahead of Potential Record-Breaking IPO
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off 



